Transchem Fair Value
Transchem (TRANSCHEM) average fair value is ₹293.74 across 5 valuation models — P/E Based Valuation, P/B Based Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹175.65 (+67.23%), fair value range ₹62.65–₹1096.95. See Transchem P/B valuation to compare market price against book value per share.
Fair Value Analysis Export
TRANSCHEM Fair Value vs Current Price — Valuation Summary
TRANSCHEM average fair value, fair value range, price gap and valuation status across 5 models: P/E Based Valuation, P/B Based Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF). Also explore TRANSCHEM price movement history to track price trends across different timeframes.
P/E Based Valuation
P/B Based Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
TRANSCHEM Fair Value Analysis — Data Sources & Coverage
Transchem financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. For live price and a broader fundamental view, visit Transchem stock price NSE.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
TRANSCHEM vs Healthcare Sector Peers — P/E, P/B & Market Cap
Transchem P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| Accretion Pharmaceuticals | ACCPL | 17.91 | 2.7 | ₹120 |
| Jeena Sikho Lifecare | JSLL | 40.38 | 23.07 | ₹7,944 |
| Par Drugs & Chemical | PAR | 8.2 | 0.96 | ₹103 |
| Aurobindo Pharma | AUROPHARMA | 25.16 | 2.5 | ₹87,806 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.